---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-107345"
form_type: "8-K"
ticker: "IRIX"
cik: "0001006045"
company_name: "IRIDEX CORP"
filed_at: "2025-08-12T23:59:59+00:00"
generated_at: "2026-05-17T14:11:51.846323+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Iridex Q2 revenue $13.6M (+7% YoY), net loss narrows to $1.0M; third straight positive adjusted EBITDA

## Summary
- Revenue $13.6M, up 7% YoY and 14% sequential; retina product revenue $8.0M (+10% YoY).
- Cyclo G6 revenue $3.3M (flat YoY); sold 13,100 probes vs 15,100, and 35 systems vs 28.
- Gross margin 34.5% vs 40.7% a year ago due to higher costs and product mix.
- Operating expenses down 28% YoY to $5.6M; net loss $1.0M ($0.06/sh) vs $2.7M ($0.16/sh).
- Non-GAAP adjusted EBITDA positive $21k, vs loss of $1.7M; cash $6.8M, down $0.4M in quarter.

## SEC filing metadata
- accession: 0000950170-25-107345
- form_type: 8-K
- ticker: IRIX
- cik: 0001006045
- company_name: IRIDEX CORP
- filed_at: 2025-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006045/000095017025107345/0000950170-25-107345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006045/000095017025107345/irix-20250812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-107345
- JSON: https://secwatch.observer/filing/0000950170-25-107345.json
- Plain text: https://secwatch.observer/filing/0000950170-25-107345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.